Antibodies to active zone protein ERC1 in Lambert-Eaton myasthenic syndrome

Human Immunology

Volumn 74, Issue 7, 2013, Pages 849-851

  Huijbers, Maartje G ^a   Lipka, Alexander F ^a   Potman, Marko ^a   Hensbergen, Paul J ^a   Titulaer, Maarten J ^a   Niks, Erik H ^a   van der Maarel, Silvère M ^a   Klooster, Rinse ^a   Verschuuren, Jan J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ERC1 ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; LUNG SMALL CELL CANCER; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CALCIUM CHANNELS; CELL LINE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; NERVE TISSUE PROTEINS; SMALL CELL LUNG CARCINOMA;

EID: 84878573294     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.03.004     Document Type: Article

References (12)

1. Titulaer M.J., Lang B. Verschuuren JJ Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 2011, 10(12):1098-1107.
2. Motomura M., Lang B., Johnston I., Palace J., Vincent A., Newsom-davies J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997, 147(1):35-42.
3. Titulaer M.J., Maddison P., Sont J.K., et al. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol 2011, 29(7):902-908.
4. de Morrée A., Hensbergen P.J., van Haagen H.H., et al. Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and intergrity. Plos One 2010, 5(11):e13854.
5. Titulaer M.J., Klooster R., Potman M., et al. Sox antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 2009, 27(26):4260-4267.
6. Lai M., Huijbers M.G., Lancaster E., et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 8:776-785.
7. Hida Y., Ohtsuka T. CAST and ELKS proteins: structural and functional determinants of the presynaptic active zone. J Biochem 2010, 148(2):131-137.
8. Ducut Sigala J.L., Bottero V., Young D.B., Shevchenko A., Mercurio F., Verma I.M. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 2004, 304(5679):1963-1967.
9. 2+ channel subunit 4 interact and colocalize at cerebellar synapses. Neuroreport 2012, 23(1):49-54.
10. Prior C., Lang B., Wray D., Newsom-Davis J. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol 1985, 17(6):587-592.
11. Benatar M., Blaes F., Johnston I., et al. Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol 2001, 113(1):153-162.
12. Takamori M. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. J Neuroimmunol 2008, 201-202:145-152.